Showing results (1281-1290 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|April 14, 2026
A pilot study of pharmacogenomic testing as a tool to enhance depression care in VeteransKevin P Kennedy, Kevin G Lynch, Ryan Bremseth-Vining, et al.
The Pharmacogenomics Journal|April 23, 2026
A randomized trial to evaluate attitudes regarding pharmacogenomics among pregnant and pediatric populations: design and baseline characteristicsAlexandra C Sundermann, Salisha E Marryshow Batson, Elizabeth A Jasper, et al.
The Pharmacogenomics Journal|May 12, 2010
CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and SpaniardsP Dorado, M G Sosa-Macias, E M Peñas-Lledó, et al.
The Pharmacogenomics Journal|March 30, 2011
Informed consent in the context of pharmacogenomic research: ethical considerationsH C Howard, Y Joly, D Avard, et al.
The Pharmacogenomics Journal|October 26, 2016
Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantationP Huezo-Diaz Curtis, C R S Uppugunduri, J Muthukumaran, et al.
The Pharmacogenomics Journal|February 28, 2008
Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactionsM R Nelson, S-A Bacanu, M Mosteller, et al.
The Pharmacogenomics Journal|April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysisM M Dias, J-P Pignon, C S Karapetis, et al.
The Pharmacogenomics Journal|March 26, 2014
Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapyF Graziano, V Catalano, P Lorenzini, et al.
The Pharmacogenomics Journal|November 30, 2016
Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than CaucasiansJ Vendelbo, R H Olesen, J K Lauridsen, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
Pageof 135